Similar articles for PMID: 11841137

Year	Number of Results
1994	1
1995	1
1996	4
1997	3
1998	3
1999	7
2000	5
2001	10
2002	11
2003	5
2004	20
2005	5
2006	3
2007	3
2008	1
2012	1
2013	1
2014	1
2016	1
2024	0

1

Higher expectations for management of heart failure: current recommendations.

Abraham WT, Scarpinato L. Abraham WT, et al. J Am Board Fam Pract. 2002 Jan-Feb;15(1):39-49. J Am Board Fam Pract. 2002. PMID: 11841137 Free article. Review.

2

Slowing the progression of heart failure.

Cohn JN. Cohn JN. Eur Heart J. 1996 Nov;17(11):1609-11. doi: 10.1093/oxfordjournals.eurheartj.a014737. Eur Heart J. 1996. PMID: 8922902 No abstract available.

3

Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.

Gattis WA, O'Connor CM, Gallup DS, Hasselblad V, Gheorghiade M; IMPACT-HF Investigators and Coordinators. Gattis WA, et al. J Am Coll Cardiol. 2004 May 5;43(9):1534-41. doi: 10.1016/j.jacc.2003.12.040. J Am Coll Cardiol. 2004. PMID: 15120808 Free article. Clinical Trial.

4

Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilization and costs. U.S. Carvedilol Heart Failure Study Group.

Fowler MB, Vera-Llonch M, Oster G, Bristow MR, Cohn JN, Colucci WS, Gilbert EM, Lukas MA, Lacey MJ, Richner R, Young ST, Packer M. Fowler MB, et al. J Am Coll Cardiol. 2001 May;37(6):1692-9. doi: 10.1016/s0735-1097(01)01190-1. J Am Coll Cardiol. 2001. PMID: 11345386 Free article.

5

Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?

Fowler MB. Fowler MB. Eur Heart J. 1998 Dec;19 Suppl P:P17-25. Eur Heart J. 1998. PMID: 9886708 Review.

6

Carvedilol: the new role of beta blockers in congestive heart failure.

Vanderhoff BT, Ruppel HM, Amsterdam PB. Vanderhoff BT, et al. Am Fam Physician. 1998 Nov 1;58(7):1627-34, 1641-2. Am Fam Physician. 1998. PMID: 9824960 Free article. Review.

7

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH. Packer M, et al. N Engl J Med. 1996 May 23;334(21):1349-55. doi: 10.1056/NEJM199605233342101. N Engl J Med. 1996. PMID: 8614419 Free article. Clinical Trial.

8

Emerging trends in the management of heart failure: Beta blocker therapy.

Sauls JL, Rone T. Sauls JL, et al. Nurs Clin North Am. 2005 Mar;40(1):135-48. doi: 10.1016/j.cnur.2004.10.002. Nurs Clin North Am. 2005. PMID: 15733952 Review.

9

Cost effectiveness of carvedilol for heart failure.

Delea TE, Vera-Llonch M, Richner RE, Fowler MB, Oster G. Delea TE, et al. Am J Cardiol. 1999 Mar 15;83(6):890-6. doi: 10.1016/s0002-9149(98)01066-2. Am J Cardiol. 1999. PMID: 10190405

10

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).

Komajda M, Lutiger B, Madeira H, Thygesen K, Bobbio M, Hildebrandt P, Jaarsma W, Riegger G, Rydén L, Scherhag A, Soler-Soler J, Remme WJ; CARMEN investigators and co-ordinators. Komajda M, et al. Eur J Heart Fail. 2004 Jun;6(4):467-75. doi: 10.1016/j.ejheart.2003.12.019. Eur J Heart Fail. 2004. PMID: 15182773 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

86 results

Results by year